25 July, 2015    Salt Lake City CA , USA
Using didactic presentations in conjunction with lively and instructive debates, this exciting and comprehensive conference will give practicing clinicians a thorough analysis of all currently available and emerging data. Recognized thought leaders will discuss and debate a variety of controversial topics, including management strategies for common mutations in lung cancer and utilization of molecular biomarker profile of the tumors to guide therapeutic decisions.

Upon successful completion of this CME activity, you will have increased confidence in your ability to select evidence-based treatment options for newly diagnosed and recurrent lung cancers, with consideration of the best combinations and sequence of agents, optimal use of multimodality therapy and timing of therapy.

Important Dates
Early Registration Deadline June 25, 2015
Discounted Registration Deadline July 9, 2015
Presentation Dates July 25, 2015


Location: Hilton La Jolla Torrey Pines
Contact 10950 N. Torrey Pines Road La Jolla , USA


11675 Rainwater Drive, Suite 600 Alpharetta, GA 30009, USA
+1 (770) 751 7332, 1 (800) 233 0957